Atlas Trials

StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies

Clinical trial NCT02765997 · WITHDRAWN

Trial details

NCT number
NCT02765997
Sponsor
Masonic Cancer Center, University of Minnesota
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaMyelodysplasia
Start date
2017-04-01
Primary completion
2020-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.